Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$2.1B
Avg Funding
$84.6M
Cities
23

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
South San Francisco, United States
$175.0M
raised

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$76.0M
raised

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chicago, United States
$30.0M
raised

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Branford, United States
$31.0M
raised

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sioux Falls, United States
$85.0M
raised

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$60.0M
raised

Ovid Therapeutic's purpose is to solve intractable medical problems.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$8.7M
raised

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Altos, United States
$50.0M
raised

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mississauga, Canada
$16.0M
raised

MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$5.0M
raised

9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$35.0M
raised

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Irvine, United States
$125.0M
raised

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$5.0M
raised

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami, United States
$30.0M
raised

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$589K
raised

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New Haven, United States
$8.0M
raised

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$719.0M
raised

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$2.0M
raised

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$10.0M
raised

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stevenage, United Kingdom
$26.1M
raised

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$250.0M
raised

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$350.0M
raised

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Coolum Beach, Australia
$4.9M
raised

Terragen offers natural and sustainable solutions for farming by creating products that improve health and condition of animals and plants.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$8.0M
raised

Mustang Bio is a clinical-stage biopharmaceutical company .

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saint Laurent, Canada
$4.6M
raised

Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked